References
- Haioun C., Lepage F., Gisselbrecht C., et al. High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma. Anals of Oncology 1998; 9(Suppl. I), S5-S8
- Philip T, Armitage J O, Spitzer G, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493
- Gribben J G, Linch D C, Singer C RJ, et al. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. Blood 1989; 73: 340
- Vose J M, Anderson J R, Bierman P J, et al. High-dose chemotherapy autologous hematopoietic stem cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1846–1851
- Perry A R, Goldstone A H. High-dose therapy for diffuse large-cell lymphoma in first remission. Annals of Oncology 1998; 9(Suppl. 1), S9-S14
- Vose J M. High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma. Anals of Oncoogy 1998; 9(Suppl.l)S1-S3
- Burke P J, Vaughan W P, Karp J E. A rationale for sequential high-dose chemotherapy of leukemia timed to coincide with induced tumor proliferation. Blood 1980; 55: 960
- Geller R B, Burke P J, Karp J E, et al. A two step timed sequential treatment for AML. Blood 1989; 74: 1499
- Mendoza F., Territo M, Schiller G, Lill M, Kunkel L, Wolin M. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplantation 1995; 15: 299–303
- Mounier N, Gisselbrecht C. Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma. Annals of Oncology 1998; 9(Suppl. 1), s15-S21
- Johnson R, McCabe F, Yu Y (1992) Combination regimens with topotecan in animal tumor models. Proceedings of the Seventh NCI-EORTC Symposium on New Drugs in Cancer Therapy. 1992. Kluwer, Amsterdamthe Netherlands, Academic. P85(abstr)
- Bertrand R, Connor O., Kerrigan D, et al. Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon-carcinoma HT-29 cells. Eur J Cancer 1992; 28A: 743–748
- Anzai H, Frost P, Abbruzzese J L. Synergistic cytotoxicity with combined inhibition of topoisomerase I and II. Proc Am Assoc Cancer Res 1992; 33: 431, (abstr)